The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•13 February 2026•

1 min read

Pfizer to Receive $29 Million from SEC Insider Trading Settlement Fund

Meta and Google logos above social media interfaces, stop signs, legal symbols, and a downward chain with a dollar sign. App logos below.

Pfizer has reached a settlement with the U.S. Securities and Exchange Commission (SEC) to receive $29 million from a dedicated recovery fund. The payment originates from a $602 million fund established following an insider trading scandal involving a unit of Steven Cohen's hedge fund. Pfizer successfully asserted its status as a victim in the scheme, which involved the misuse of the pharmaceutical giant's confidential information. This settlement concludes a long-standing legal dispute over the distribution of the remaining funds within the SEC's recovery pool. While the recovery provides a minor positive cash inflow, the amount is considered financially insignificant relative to Pfizer's overall scale and market capitalization. The resolution marks the end of a legal chapter tied to one of the most high-profile insider trading cases in recent history.

Sources: